For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
Scope of the Report:
This report focuses on the Overactive Bladder Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
The worldwide market for Overactive Bladder Treatment is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 6460 million US$ in 2023, from 4710 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Astellas Pharma
- Teva (Activas)
- Johnson & Johnson
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Idiopathic Overactive Bladder
- Neurogenic Overactive Bladder
There are 15 Chapters to deeply display the global Overactive Bladder Treatment market.
Chapter 1, to describe Overactive Bladder Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Overactive Bladder Treatment, with sales, revenue, and price of Overactive Bladder Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Overactive Bladder Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Overactive Bladder Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Overactive Bladder Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source